1. Introduction
===============

Marine sponges of the genus *Callyspongia* are known as common sources of structurally unique and biologically active natural products, such as polyacetylenes \[[@B1-molecules-15-00871]\], peptides \[[@B2-molecules-15-00871]\], terpenoids \[[@B3-molecules-15-00871]\], alkaloids \[[@B4-molecules-15-00871]\], fatty acids \[[@B5-molecules-15-00871]\], polyketides \[[@B6-molecules-15-00871]\], sterols \[[@B7-molecules-15-00871]\], peroxides \[[@B8-molecules-15-00871]\], and butenolides \[[@B9-molecules-15-00871]\]. Some of these compounds possess antifouling \[[@B10-molecules-15-00871]\], cytotoxic \[[@B11-molecules-15-00871]\], anticancer \[[@B6-molecules-15-00871]\], and antimicrobial \[[@B10-molecules-15-00871]\] properties.

In our study of bioactive compounds from *Callyspongia* sp. marine sponges collected from the coast of Hainan, the new 1,4-diazepine **1**, as well as proline-based diketopiperazines **2**--**5** were obtained. The structure of the new compound was elucidated by the aid of COSY, HSQC, HMBC, and MS experiments, while the absolute stereochemistry of **1** was defined by NOESY spectroscopy and optical rotation. Compounds **2**--**5** were identified as cyclo-(*S*-Pro-*R*-Leu) (**2**) \[[@B12-molecules-15-00871]\], cyclo-(*S*-Pro-*R*-Val) (**3**) \[[@B12-molecules-15-00871]\], cyclo-(*S*-Pro-*R*-Ala) (**4**) \[[@B13-molecules-15-00871]\], and cyclo-(*S*-Pro-*R*-Tyr) (**5**) \[[@B14-molecules-15-00871]\], respectively, by comparison of their spectroscopic data with those reported in the literature.

2. Results and Discussion
=========================

The aqueous EtOH extract of the *Callyspongia* sp. marine sponge was suspended in water, and partitioned successively with petroleum ether, EtOAc, and *n*-butanol. The EtOAc and *n*-butanol fractions were subjected to silica column, Sephadex LH-20, and ODS-HPLC, to yield compounds **1**--**5**([Figure 1](#molecules-15-00871-f001){ref-type="fig"}).

![Structures of compounds **1**--**5**.](molecules-15-00871-g001){#molecules-15-00871-f001}

Compound **1**was obtained as yellow oil and had the molecular formula C~9~H~14~N~2~O~2~S, as deduced from the HREI mass spectrum (*m*/*z* 214.0774 \[M\]^+^; calc. for C~9~H~14~N~2~O~2~S, 214.0776) and NMR data ([Table 1](#molecules-15-00871-t001){ref-type="table"}), the latter being unambiguously assigned by aid of COSY, HMQC, and HMBC experiments. ^1^H-NMR ([Table 1](#molecules-15-00871-t001){ref-type="table"}) chemical shifts of two *α*-methine protons at *δ*~H~ 4.36 and 4.11, and ^13^C-NMR ([Table 1](#molecules-15-00871-t001){ref-type="table"}) chemical shifts of two carbonyl carbons at *δ*~C~ 170.2 and 165.4, supported the presence of a peptide fragment. The fact that compound **1** was negative to the ninhydrin test, suggested a cyclic or a *N*-terminus-blocked peptide \[[@B15-molecules-15-00871]\]. The ^1^H-NMR spectrum of **1** showed the presence of one methyl signal at *δ*~H~ 1.34 (d, *J* = 6.5 Hz, 3H), one thiol proton at *δ*~H~ 1.89 (m, 1H), three consecutive methylene signals (*δ*~H~ = 2.0--3.7), and three methine signals at *δ*~H~ 3.97 (br d, *J* = 3.0 Hz, 1H), 4.11 (t, *J* = 7.5 Hz, 1H), and 4.36 (dt, *J* = 6.5, 3.0 Hz, 1H), and one acid amide proton at *δ*~H~ 6.73 (s, 1H). The ^13^C-NMR spectrum of **1** showed the presence of two carbonyl carbons (*δ*~C~ 170.2 and 165.4), two *N*-methine carbons (*δ*~C~ 65.6 and 59.0), one *N*-methylene carbon (*δ*~C~ 45.3), one *S*-methine carbon (*δ*~C~ 59.4), and one methyl carbon (*δ*~C~ 18.9). The remaining carbons were assigned to two methylene carbons (*δ*~C~ 28.1 and 22.6). The COSY spectra ([Figure 2](#molecules-15-00871-f002){ref-type="fig"}) indicated three consecutive methylenes (*δ*~H~ 2.0--3.7) characteristic of a proline residue \[[@B16-molecules-15-00871]\], and showed correlations of H-9 with H-10 and H-11. The assignments of a remaining C~3~H~6~S fragment, and one site of unsaturation were carried out by 2D NMR experiments. Key HMBC correlations H-9/C-7, H-3a/C-1, H-3a/C-6, H-3b/C-1, H-3b/C-6, H-11/C-9, and H-11/C-10, as well as COSY connectivities ([Figure 2](#molecules-15-00871-f002){ref-type="fig"}), were indicative of a pyrrolidine-fused seven-membered diazepine ring. The placement of a methyl group at C-9, and a thiol group at C-10, were deduced from the COSY correlations H-11/H-9, and SH-12/H-10, respectively.
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^1^H- (500 MHz) and ^13^C-NMR (125 MHz) data of compound **1** (in CDCl~3~, *δ* in ppm, *J* in Hz).

  No.           *δ* ~c~          *δ* ~H~               HMBC (H to C)
  ------------- ---------------- --------------------- ----------------
  1             165.4            --                    --
  2             --               --                    --
  3             45.3             3.51 (m)              C-1, 4, −5, −6
  3.61 (m)      C-1, 4, −5, −6                         
  4             22.6             2.00 (m)              C-3, −5, −6
  2.06 (m)      C-3, −5, −6                            
  5             28.1             2.34 (m)              C-4, −6, −7
  C-4, −6, −7                                          
  6             59.0             4.11 (t, 7.5)         C-4, −5, −7
  7             170.2            --                    --
  8             --               6.73 (s)              --
  9             65.6             4.36 (dt, 6.5, 3.0)   C-7, −11
  10            59.4             3.97 (d, 3.0)         C-1, −9, −11
  11            18.9             1.34 (d, 6.5)         C-9, −10
  12            --               1.89 (m)              --

The absolute configuration of compound **1** was determined by the optical rotation, NOESY spectrum and analysis of the coupling constants (*J*), along with inspection of the molecular model. In the NOESY spectrum ([Figure 3](#molecules-15-00871-f003){ref-type="fig"}), the key NOE correlations of H-9/H-10 and H-6/H-11 showed that H-9 and H-10, H-6 and H-11 were on the same face, so the relative stereochemistry was determined. The coupling patterns of the H-9 (dt, *J* = 3.0 and 6.5 Hz) and H-10 (d, *J* = 3.0 Hz) led to confirmation of the *cis*-orientation of H-9/H-10 and possessed *β*-orientation \[[@B17-molecules-15-00871]\], and thus the configuration of C-9 and C-10 were determined as *R\** and *S\**, respectively. The sign of \[*α*\]~D~ for proline-containing DKPs is either negative or positive, depending only on the absolute configuration of Pro \[[@B12-molecules-15-00871]\]. On the basis of the sign of \[*α*\]^20^~D~ (−52.6) and by comparison of the NMR data of the proline residue with those of proline-containing DKPs \[[@B12-molecules-15-00871],[@B13-molecules-15-00871],[@B14-molecules-15-00871]\], which suggested C-6 has (*S*)-configuration, Pro in **1** has therefore (*S*)-configuration, and the above data approved the absolute configuration of compound **1** as the new (6*S*, 9*R*, 10*S*)-1,4-diazepine.

The structures of known compounds **2**--**5**were confirmed by detailed NMR data comparison with those in the literature \[[@B12-molecules-15-00871],[@B13-molecules-15-00871],[@B14-molecules-15-00871]\]. The absolute configuration of **2**--**5** were determined by comparison with reported optical rotation values \[[@B12-molecules-15-00871],[@B13-molecules-15-00871],[@B14-molecules-15-00871]\].

Compound **1** was evaluated for cytotoxicity by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) method \[[@B18-molecules-15-00871]\], and showed a marginal activity against a small panel of three human tumour HepG2 (hepatoma carcinoma cell), A549 (lung carcinoma cell), and HeLa (cervical cancer cell) cell lines, their inhibition ratio were lower than 10% at concentration of 100 μg/mL with the IC~50~ values of the positive control compound 5-Fu 13.70, 2.13, and 3.83 μg/mL, respectively.

![Key HMBC and COSY correlations of **1**.](molecules-15-00871-g002){#molecules-15-00871-f002}

![Key NOE correlations of compound **1**.](molecules-15-00871-g003){#molecules-15-00871-f003}

3. Experimental
===============

3.1. General
------------

NMR spectra were recorded on a Bruker AC 500 NMR spectrometer with TMS as an internal standard. ESI-MS data were measured on a Agilent 1200 LC-MS spectrometer. HREIMS data were obtained from MAT 95XP (Thermo) mass spectrometer. The silica gel GF~254~ plates used for TLC were supplied by the Qingdao Marine Chemical Factory (Qingdao, China). Analytical HPLC was performed on a Hitachi L-2400 HPLC system, using a YMC ODS-H80 column (250 × 4.6 mm i.d., 4 μm) coupled to an Alltech ELSD 800 detector; semi-preparative HPLC was performed on a Hitachi L-2400 HPLC system, using a YMC ODS-H80 column (250 × 10 mm i.d., 4 μm) coupled to an Alltech ELSD 800 detector with flow-splitter valve (Parker: NS) set at a split ratio of 20:1 (collector: detector). Optical rotation data were measured by Perkin-Elmer Model 341 polarimeter. Spots were detected on TLC under UV light or by heating after spraying with 5% H~2~SO~4~ in EtOH (v/v).

3.2. Animal Material
--------------------

The sponge is an undescribed species of *Callyspongia* (order Haplosclerida, family Callyspongiidae) collected off the coast of Hainan Island, South China Sea, in January, 2007. The specimen was identified by Dr. Kyung Jin Lee. A voucher specimen (No. 20070101) was deposited in Natural History Museum, Hannam University, Daejon, Korea and Key Laboratory of Marine Bio-resources Sustainable Utilization, South China Sea Institute of Oceanology, Chinese Academy of Sciences, China.

3.3. Extraction and Isolation
-----------------------------

The wet sponges (10 kg) were extracted three times with EtOH/H~2~O (90:10, 20 L). The aqueous EtOH extract was concentrated under vacuum. The combined extract was partitioned between EtOAc and H~2~O. The EtOAc soluble portion (28 g) was partitioned between petroleum ether and EtOH/H~2~O (7:3, 500 mL). The EtOH/H~2~O soluble portion (8.0 g) was chromatographed on a silica gel column (80 g) eluted with petroleum ether (500 mL, fraction A), petroleum ether/EtOAc (8:2, 500 mL, fraction B), petroleum ether/EtOAc (1:1, 500 mL, fraction C), petroleum ether/EtOAc (3:7, 500 mL, fraction D), petroleum ether/ EtOAc (1:9, 500 mL, fraction E), EtOAc (500 mL, fraction F), EtOAc/acetone (1:1, 500 mL, fraction G), and MeOH (500 mL, fraction H), to give eight fractions. Fraction D (1.06 g) was subjected to column chromatography (CC) with gradient EtOAc/acetone (10:0, 250 mL; 8:2, 250 mL; 7:3, 250 mL; 5:5, 250 mL) to give four subfractions (D1--D4). Fraction D1 (45.2 mg) was purified by Sephadex LH-20 (CHCl~3~/MeOH, 2:8, 250 mL) to afford **3**(13.3 mg). Fraction D4 (90.1 mg) was purified by Sephadex LH-20 (CHCl~3~/MeOH, 2:8, 250 mL) to yield **2**(23.4 mg). Fraction G3-2 (112.3 mg) was purified by Sephadex LH-20 (CHCl~3~/MeOH, 2:8, 250 mL) to yield fraction G3-2-1 (80.2 mg). Fraction G3-2-1 was further subjected to CC with CHCl~3~/MeOH (98:2, 150 mL) to give **4** (4.3 mg). Fraction G6 (300.1 mg) was subjected to CC with CHCl~3~/MeOH (9:1, 250 mL) to give two subfractions (G6-1, G6-2). Fraction G6-1 (122.6 mg) was further purified by Sephadex LH-20 (CHCl~3~/MeOH, 2:8, 150 mL) to afford fraction G6-2-1 (68.1 mg). Fraction G6-2-1 was further purified by reverse-phase HPLC (ODS, MeOH/H~2~O, 5:5, 180 mL;) to yield **5**(7.2 mg). The *n*-butanol soluble portion (80 g) was chromatographed on ODS column eluted with MeOH/H~2~O (0:100, 2,000 mL; 10:90, 2,000 mL; 20:80, 2,000 mL; 40:60, 2,000 mL; 60:40, 2,000 mL; 100:0, 2,000 mL) to give six fractions I, J, K, L, M, N. Fraction J (20 g) was subjected to CC with gradient CHCl~3~/MeOH (100:0, 500 mL; 90:10, 500 mL; 80:20, 500 mL; 60:40, 500 mL; 40:60, 500 mL; 0:100, 500 mL;) to give six fractions (J1--J6). Fraction J1 was further purified by reverse-phase HPLC (ODS, MeOH/H~2~O, 5:95, 150 mL) to yield **1**(6.9 mg, 2.8 × 10^−3^ % of the total extractum 250.0 g).

*Callysponine* (**1**). White amorphous powder; \[*α*\]^20^~D~ = −52.6 (*c* = 0.41, MeOH); NMR data (CD~3~OD), see [Table 1](#molecules-15-00871-t001){ref-type="table"}; ESI-MS (*m/z*): 237 \[M+Na\]^+^, 213 \[M-H\]^−^; HREIMS (*m/z*): 214.0774 \[M\]^+^(calc. for C~9~H~14~N~2~O~2~S, 214.0776).

*Cyclo-(S-Pro-R-Leu)*(**2**). White crystals; \[*α*\]^20^~D~ = −78.3 (*c* = 0.03, MeOH).

*Cyclo-(S-Pro-R-Val)* (**3**). White crystals; \[*α*\]^20^~D~ = −102.6 (*c* = 1.36, MeOH).

*Cyclo-(S-Pro-R-Ala)* (**4**). White solid; \[*α*\]^20^~D~ = −40.4 (*c* = 0.45, MeOH).

*Cyclo-(S-Pro-R-Tyr)* (**5**). Viscous oil; \[*α*\]^20^~D~ = −9.3 (*c* = 0.91, MeOH).

4. Conclusions
==============

A new 1,4-diazepine, callysponine (**1**), was isolated from South China Sea *Callyspongia*sp. marine sponge, together with four known proline-based diketopiperazines. Callysponine did not show activities against HepG2, A549, and HeLa cell lines.
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